Major trial for new Ebola vaccine begins in DR Congo amid outbreak

The DRC has launched the Phase 2/3 "Tumaini" clinical trial in Bunia to evaluate candidate vaccines against the Bundibugyo Ebola virus during its largest recorded outbreak. Using a ring vaccination approach for high-risk contacts, the trial aims to evaluate safety and efficacy to combat an epidemic